Clinical Study Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 2002

Oxygenation measurements in head and neck cancers during hyperbaric oxygenation.

Becker A, Kuhnt T, Liedtke H, Krivokuca A, Bloching M, Dunst J — Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2002

View Original on PubMed PMID 11942033

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers measured tumor oxygen levels in seven head and neck cancer patients before, during, and after hyperbaric oxygenation (HBO) to assess changes.

What They Found

Before HBO, the median tumor pO2 was 8.6 ± 5.4 mm Hg (Eppendorf) and 17.3 ± 25.5 mm Hg (Licox probe). During HBO, the pO2 significantly increased to 550 ± 333 mm Hg, demonstrating a substantial improvement in oxygenation.

What This Means for Canadian Patients

This study suggests that hyperbaric oxygenation can significantly increase oxygen levels in head and neck tumors. For Canadian patients, this could potentially enhance the effectiveness of radiation therapy by making tumors less hypoxic and more responsive to treatment.

Canadian Relevance

This study has no direct Canadian connection as it was conducted in Germany.

Study Limitations

A significant limitation of this study is the very small sample size of only seven patients, which limits the generalizability of the findings.

Was this summary helpful?

Study Details

Study Type	Clinical Study
Category	Decompression Sickness
Source	Pubmed
PubMed ID	11942033
Year Published	2002
Journal	Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
MeSH Terms	Carcinoma, Squamous Cell; Cell Hypoxia; Female; Head and Neck Neoplasms; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Treatment Outcome

Related Research

Undersea Hyperb Med | 2026 Study

Registered Nurses in Hyperbaric Medicine: Increasing Patient Compliance with Hyperbaric Oxygen Therapy

Hurlburt S, Orwig D

Undersea Hyperb Med | 2026 Cohort Study

Risk Factors of Dysbaric Osteonecrosis in Saturation Diving Identified through Magnetic Resonance Imaging Surveillance

Miyoshi Y, Watanabe S, Tsukazaki S, Sugiura T, Ikomi F, Tanaka T, et al.

Sci Rep | 2026 Study

Therapeutic Potential of GYY4137 in Reducing Oxidative Stress and Mortality in Experimental Decompression Sickness

Daubresse L, Marlinge M, Lavner H, Dodivers J, Bertaud A, Lledo S, et al.

IJU Case Rep | 2026 Study

A Case of Cerebral Air Embolization During Robot-Assisted Partial Nephrectomy via a Retroperitoneal Approach for the Patient With Renal Cell Carcinoma

Matsumoto T, Kaitsumaru M, Tsukino K, Mutaguchi J, Tsukahara S, Tanegashima T, et al.

Undersea Hyperb Med | 2026 Case Report

Dysbaric osteonecrosis: Case series osteonecrosis in divers

Amamri A, Miliani A, Boudour R, Mellal Y, Dib M, Medaouar M, et al.

See all Decompression Sickness research

View on PubMed Back to Research Library

Find a Canadian Clinic Treating Decompression Sickness

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.